A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

Abstract The emergence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) variants has altered the trajectory of the COVID‐19 pandemic and raised some uncertainty on the long‐term efficiency of vaccine strategy. The development of new therapeutics against a wide range of SARS‐CoV‐2 vari...

Full description

Bibliographic Details
Main Authors: Yi‐Chung Chang, Chi‐Fan Yang, Yi‐Fen Chen, Chia‐Chun Yang, Yuan‐Lin Chou, Hung‐Wen Chou, Tein‐Yao Chang, Tai‐Ling Chao, Shu‐Chen Hsu, Si‐Man Ieong, Ya‐Min Tsai, Ping‐Cheng Liu, Yuan‐Fan Chin, Jun‐Tung Fang, Han‐Chieh Kao, Hsuan‐Ying Lu, Jia‐Yu Chang, Ren‐Shiuan Weng, Qian‐Wen Tu, Fang‐Yu Chang, Kuo‐Yen Huang, Tong‐Young Lee, Sui‐Yuan Chang, Pan‐Chyr Yang
Format: Article
Language:English
Published: Springer Nature 2022-02-01
Series:EMBO Molecular Medicine
Subjects:
COVID‐19
inhalation
K18‐hACE2‐transgenic mice
SARS‐CoV‐2
siRNA
Online Access:https://doi.org/10.15252/emmm.202115298

Internet

https://doi.org/10.15252/emmm.202115298

Similar Items